Khurana & Khurana, Advocates and IP Attorneys (K&K) is more than a full service Intellectual Property and Commercial Law firm. K&K was formed in the year 2007 with a very firm focus of providing end-to-end IP Prosecution/Litigation and Commercial Law services in a manner that is Corporate centric and follows stringent delivery practices that are consistent and are above defined quality standards. K&K works closely with its sister concern IIPRD, both of which supplement each other in order to provide end-to-end IP Legal and Commercialization/Licensing services to over 3000 Corporates. K&K is a team of over 65 professionals spread across 5 Offices in India, and has strong rankings from Legal 500, MIP, IAM, Chambers, Asia IP, among others.
Our team of IP Attorneys/Practitioners, having high level of technical and legal competence, gives us the right competitive edge and positioning, as a law firm focused on creating immense IP value for our clients. K&K through its experienced and qualified team of Attorneys/Practitioners, across Technology and Legal Domains, gives a rare synergy of legal opinion, out-of-box thinking for protection of ideas/IP's and entrepreneurial spirits to its client base. K&K earnestly believes that success comes only when one has a long-term perspective and this is why we concentrate on building long-term relationships through high level of client orientation.
K&K's critically focuses on a broad range of Technology Consulting and IP Research Services spanning all stages of IP Procurement, Management, and Enforcement. K&K has a diligent and earnest team of strong Patent, Commercial, and Legal Professionals who enable the firm to provide the complete spectrum of services starting from Market/Technology Research to Licensing/Commercialization to Litigation Support. K&K's over 8 years of substantive experience has helped it gain a prominent name in the Industry as a reliance and trustworthy partner in the complete Research and Analytics Process.
Khurana & Khurana, Advocates and IP Attorneys has been established precisely to help corporate leverage anticipated business and economic value from its efficient creation, protection and enforcement of their Intellectual Properties. Khurana & Khurana has created a unique and strategic position for itself by giving End-to-End IP services to its clients from the inception stage of creation of IP to successful commercialization of the IP for fulfillment of desired business objectives. The role and importance of patent professionals in IP (intellectual property) portfolio management (IPM) are increasing becoming significant within business, academic, and legal entities.View more
Khurana & Khurana has a legacy of over ten years in Patent Litigation and serves some of the leading Corporates for IP infringement matters. Our experience includes finding the potential infringers for the IP owners through due diligence and assessing the market for the same. For doing this, our firm has Patent/Trade Mark Attorneys/Practitioners who have advanced qualifications in varied technology domains and understand complete nuances of claim mapping and provisions of enforcement under different IP Laws.View more
Khurana & Khurana assists Corporates in maximizing opportunities from their IP portfolios through accurate legal opinions that ensure that all possible ways to solve a problem are identified and due-diligence of each way is put across in the right manner such that the client can take a judicious call on the way to proceed forward. K&K renders Prior art, Freedom to Operate, Validity, and Non-infringement opinions relating to a client’s products and technologies. K&K also prepares a comprehensive IP Litigation Strategy before initiating with a legal suit to ensure that the clients understands the next steps clearly, sets its expectations, and is cognizant of the costs involved in the process.View more
Commercial law governs the broad areas of business, commerce and consumer transactions. Commercial law in India has developed rapidly over the years with the opening up approach towards FDI and WTO. It allows, so far as it can, Corporate or person to do business in the way they want and not require them to stick to forms that they may think to be outmoded. Thus, Commercial Law Practice is recognized as a very important and integral element of any corporate operation, and is gaining more and more importance.In this era of globalisation, sweeping changes in business strategies require Corporates to meet challenge of complying with commercial contract law for the smooth functioning of its business and commerce.View more
The Internet Corporation for Assigned Names and Numbers (ICANN) is responsible for the administration of Top Level Domain Names. The Uniform Dispute Resolution Policy provides for the settlement of domain name disputes for the Generic Top Level Domains Name (GTLD) such as .com, .edu, .net, among others. The UDRP complaints may be filed with any of the ICANN accredited arbitration centres. UDRP also allows for the filing of the complaints at the jurisdictional civil court where the Registrant or the Registrar is located. Where the Registrar or the Registrant is located in India, the dispute may be resolved through legal action at the civil court.View more
Attorneys at Khurana & Khurana have developed significant experience in the area of anti-counterfeiting, especially in FMCG, Pharmaceuticals, Apparels, Footwear, and Medical Devices product verticals, and can assist in devising a comprehensive strategy for curbing counterfeit products by outlining all possible risks and assumptions and mapping them with costs involved in each step taken so that a judicious and objective step can be taken by the client..View more
India, though in a phase of rapid economic development, still has the bane of poverty. In this country, around 22% of the population is Below the Poverty Line , and hence most of the nation’s policies are oriented towards the poor. India’s IP Policy is no different, as the IP legislature in India is mostly … Continue reading India: Do we need Patent Term Extension and Non-Patent Exclusivities for Pharmaceuticals?
After successfully conducting several symposiums in 2016, IIPRD is coming up with one-day seminar on software and electronics patent portfolio with focus on preliminary preparation, prosecution, and litigation in India and US. While the programme is being organized in Pune on February 23, the one in Bengaluru will be hosted February 24. The seminar is … Continue reading First Symposium of IIPRD in 2017
We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to rejection of Lumacaftor (Polymorph) patent application in India since last year. Here is our take: Details of the Patent Application and important dates: Patent application number in India 2056/KOLNP/2010 Title of the invention … Continue reading Analysis of the rejection of Lumacaftor (Polymorph) patent application in India
An enforceable Patent being the key to effective Commercialization/Out-Licensing of any technology needs to be drafted well. No matter how good a technology is, if the description of the technical subject matter of a Patent is not enabling or fails to disclose all necessary embodiments, and in case the claims are narrowly drafted and do … Continue reading A Primer to Patent Application Drafting with special emphasis on standard practise(s) before the Indian Patent Office
Mickey Mouse has always been synonymous with Disney, and has served as their ultimate mascot.Disney Corporation has always been protective of its creations and has ensured that their copyrights and their beloved mascot, Mickey Mouse, never fall into the public domain. Every time the first Mickey Mouse copyright is set to expire, Disney springs into … Continue reading The Mickey Mouse Debate
Anjana Mohan, an intern at Khurana & Khurana, Advocates and IP Attorneys deals with the updates in the Patent Litigation between Dolby International and two Smartphone companies Oppo and Vivo over the patented technology by Dolby. Dolby filed suits vide Suit no CS(COMM) 1425/2016 and CS(COMM) 1426/2016 against various parties including the two major Chinese … Continue reading PATENT INFRINGMENT SUIT BY DOLBY AGAINST OPPO AND VIVO
In Merck Sharp & Dohme Corp. (hereinafter referred to be as “Merck”) v. Teva Pharms. United States, Inc. (hereinafter referred to be as “Teva”) decided on November 16, 2016, Teva’s application of Abbreviated New Drug Application (hereinafter referred to as “ANDA”) no. 205149 had triggered Merck to file infringement suit against Teva in respect of … Continue reading Merk’s patent valid but Teva’s Nasonex generic non-infringing
This article is intended with covering the basic FAQs about Design registration in India. For the sake of better focusing, format of questions and answers has been adopted. Industrial Designs are protected by different laws in different countries, i.e. some countries choose to go for Patent Registration and some go for specialized systems. Unlike USA … Continue reading Simplified account of Design Registration in India
This article is intended with covering the basic FAQs about Copyright registration in India. For the sake of better focusing, format of questions and answers has been adopted. What is Copyright? Copyright is a right given by the law to creators of literary, dramatic, musical and artistic works and producers of cinematograph films and sound … Continue reading Simplified account of Copyright Registration in India
We had written an article giving a simplified account of Patenting procedures in India to enable readers who are new to the Patents. Similar attempt is being made here to provide answers to the Trademark FAQs so as to enable readers who are new to the Trademark. What is trademark? What is mark? What are … Continue reading Simplified account of Trademark Registration in India
Different countries having regard to National Security Considerations and with the intent of having a check on the defence and atomic energy related inventions, have different restrictions in place. While some countries make it mandatory to file Patent Applications in their country before applying in any other country, some countries require only prior permission before … Continue reading Foreign Filing Permission: Indian Patent System Perspective
In Roxane Laboratories, Inc. (hereinafter referred to be as “Roxane”) v. Camber Pharmaceuticals Inc., et al. (hereinafter referred to as “Camber”) decided by United States Court of Appeals for the Federal Circuit on November 17, 2016, Roxane had appealed against decision of district court in an infringement suit against Camber and Invagen Pharmaceuticals Inc (collectively … Continue reading Hetero’s Subsidiaries not infringing Roxane’s patent on PhosLo